Epidemiology And Classification

  • Significant hearing loss affects 1-3 per 1000 newborns.
  • Prevalence reaches 3.1 percent for mild or greater loss among children and adolescents.
  • Divided into peripheral and central types.

Peripheral Hearing Loss

  • Conductive hearing loss involves external or middle ear transmission impedance.
  • Sensorineural hearing loss results from inner ear or eighth cranial nerve damage.
  • Mixed hearing loss combines conductive and sensorineural defects.

Central Hearing Loss

  • Involves central auditory nervous system pathways.
  • Includes auditory neuropathy spectrum disorder and central auditory processing disorders.

Etiology Of Conductive Hearing Loss

  • Otitis media with effusion represents most common etiology.
  • Acquired causes include tympanic membrane perforation, tympanosclerosis, and cholesteatoma.
  • Congenital causes include external auditory canal atresia and ossicular malformations.
  • Frequently associated with craniofacial anomalies including Treacher Collins, Crouzon, and Down syndromes.

Etiology Of Sensorineural Hearing Loss

Infectious Causes

  • Cytomegalovirus represents most common congenital infectious cause.
  • Other prenatal infections include toxoplasmosis, syphilis, and rubella.
  • Postnatal infections include bacterial meningitis, particularly Streptococcus pneumoniae.

Genetic Causes

  • Genetic factors account for approximately 50 percent of cases.
  • Autosomal recessive transmission accounts for 80 percent of childhood genetic cases.
  • Pathogenic variants of connexin-26 gene represent most frequent nonsyndromic etiology.
Genetic InheritanceSyndromic AssociationsKey Clinical Features
Autosomal DominantWaardenburg syndromeDystopia canthorum, heterochromic irises, white forelock.
Autosomal DominantBranchiootorenal syndromePreauricular pits, branchial clefts, renal anomalies.
Autosomal RecessiveUsher syndromeVestibular areflexia, progressive retinitis pigmentosa leading to blindness.
Autosomal RecessivePendred syndromeVestibular aqueduct dilation, thyroid goiter.
Autosomal RecessiveJervell and Lange-NielsenProlonged QT interval, risk of sudden cardiac death.
Sex-LinkedAlport syndromeNephritis, microscopic hematuria, progressive hearing loss.

Physical And Toxic Causes

  • Malformations include Mondini dysplasia and enlarged vestibular aqueducts.
  • Ototoxic medications include aminoglycosides, loop diuretics, and cisplatin.
  • Acoustic trauma from high-intensity sound damages 3000-6000 Hertz frequencies.
  • Temporal bone fractures cause sudden impairment following head trauma.

Screening And Identification

  • Universal neonatal hearing screening strictly recommended for all newborns.
  • Early identification significantly improves speech and language prognosis.
  • Follow established 1-3-6 rule.
  • Complete initial screening by 1 month of age.
  • Confirm diagnosis by 3 months of age.
  • Initiate therapeutic intervention by 6 months of age.

Diagnostic Evaluation

Electrophysiologic Assessment

  • Otoacoustic emissions assess cochlear outer hair cell functional integrity.
  • Otoacoustic emissions elicit no response if hearing loss exceeds 30-40 decibels.
  • Auditory brainstem response measures neural synchrony and estimates precise thresholds.
  • Auditory brainstem response remains completely unaffected by patient sedation or general anesthesia.

Behavioral Audiometry

Age GroupTesting ModalityDiagnostic Mechanism
Under 5 monthsBehavioral observationUnconditioned reflexive responses to uncalibrated complex sounds.
6 to 30 monthsVisual reinforcementConditioned head turn toward animated mechanical or video visual reinforcer.
30 months to 5 yearsPlay audiometryConditioned motor activities upon hearing specific tonal signals.
Over 5 yearsConventional pure-toneStandard earphone assessment across full 250 to 8000 Hertz frequency spectrum.

Management And Rehabilitation

Non-Surgical Interventions

  • Hearing aids represent primary rehabilitative device for mild to severe deficits.
  • Prescribe amplification within one month of confirmed diagnosis.
  • Institute speech and language therapy early to maximize oral communication skills.
  • Explore alternative communication modalities including sign language, cued speech, and total communication.

Surgical Interventions

  • Tympanostomy tubes manage persistent conductive loss secondary to chronic otitis media with effusion.
  • Atresiaplasty or bone-anchored hearing aids treat congenital external auditory canal atresia.
  • Cochlear implantation indicated for severe to profound bilateral sensorineural loss lacking hearing aid benefit.
  • Implants bypass damaged organ of Corti to directly stimulate spiral ganglion neurons.
  • Minimum age for cochlear implantation reduced to 9 months by regulatory agencies.
  • Pre-implantation protocols require pneumococcal polyvalent vaccination to prevent subsequent meningitis complications.